|
> Human Serum
Albumin (HSA) is a large protein molecule
that will be used extensively in all vaccine
preparations as a carrier protein and in various
disease conditions. Preliminary work on cloning
and expression has been completed. The protein
would be ready for commercialization by
2012-13.
> Interferon Beta
is a small therapeutic protein molecule
that is used to treat the demyelinating disease
of the central nervous system. It is not
available in majority of the countries. At
Sudershan Biotech, we have successfully cloned
and expressed this protein. The production of
Interferon Beta would commence by year 2012-13.
> Hepatitis C Vaccine
is currently under development and the
vaccine would be ready for commercialization by
2012-13. > Erythropoietin
used for treatment of Anemia of Chronic Renal
Failure Patents, Zidovudine treated HIV infected
Patient,Cancer Patients on Chemotherapy and in
reduction of Allogenic Blood Transfusion in
Surgery Patients. The Production of erithropen
would commence by year 2012-13.
| 
top